TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life

• Main Authors: Emma Davé (Author), Oliver Durrant (Author), Neha Dhami (Author), Joanne Compson (Author), Janice Broadbridge (Author), Sophie Archer (Author), Asher Maroof (Author), Kevin Whale (Author), Karelle Menochet (Author), Pierre Bonnaillie (Author), Emily Barry (Author), Gavin Wild (Author), Claude Peerboom (Author), Pallavi Bhatta (Author), Mark Ellis (Author), Matthew Hinchliffe (Author), David P. Humphreys (Author), Sam P. Heywood (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTTrYbe® is an Fc-free therapeutic antibody format, capable of engaging up to three targets simultaneously, with long in vivo half-life conferred by albumin binding. This format is shown by small-angle X-ray scattering to be conformationally flexible with favorable 'reach' properties...